Breaking News

Eli Lilly's modernisation plan cuts 250 jobs in France

The Fegersheim site will see a €100 million investment in new technology

Univercells launches new vaccine manufacturing platform

Low-cost vaccine manufacturing technology, NevoLine, has been launched and already received grant for scale-up

AstraZeneca undergoes business shake-up

British pharma giant has aligned therapy R&D units to new commercial strategy and hired oncology expert Jose Baselga to ...

An integrated solution

How track and trace is transforming pharmaceutical QA/QC workflows

Bio-Rad publishes new findings on Drug-Target Complex-Specific Antibodies

US laboratory has released findings on the Generation and Characterisation of Drug-Target Complex-Specific Antibodies

New Upperton facilitites in Nottingham pass MHRA inspections

Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical ...

Preparing PIs for post EU-FMD success

Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel ...

Eli Lilly’s acquisition of Loxo Oncology will result in quick return of investment

Eli Lilly’s acquisition of Loxo Oncology marks the second multibillion-dollar deal in 2019 following the recent BMS and ...

Synlogic releases financial and portfolio update

Synthetic biotic platform uses momentum going into 2019

Innovation in clinical trials

Clinical trials have undergone significant technological and regulatory developments during the past decade; and now, ...

The modularisation of chemical API synthesis

The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and ...

Formulating for children: challenges and solutions

There’s much more to developing a paediatric medicine than simply scaling down the adult dose to suit the weight of the ...

Exscientia initiates sixth AI drug discovery partnership

Exscientia to receive up to CHF67 million in upfront payments, research support and milestone payments in discovery ...

Cytoreason and Pfizer to use machine learning model of the immune system for drug discovery

CytoReason, a leader in machine learning for drug discovery and development, has entered into a collaboration agreement ...